Browsing Tag
Australian Securities Exchange
92 posts
Qantas (ASX: QAN) jumps 4.8% as A$3.6bn fuel bill tests FY27 margins
Qantas rose 4.8% after FY26 results. Can 8% to 10% unit-revenue growth offset a A$3.6bn H1 fuel bill and heavy fleet spending?
Credit Corp (ASX: CCP) lands A$150m HSBC card book as FY27 profit guidance climbs
The HSBC Bank Australia portfolio purchase lifts Credit Corp’s FY27 purchased-debt investment target by A$100 million at the midpoint, while investors sent the shares 3.4% higher.
Baby Bunting (ASX: BBN) rises 5.8% as FY27 profit guide points to 8.6x P/E
Baby Bunting rose after FY26 profit jumped 34%. Can a 42% margin target and store refurbishments sustain the BBN recovery?
Treasury Wine Estates (ASX: TWE) rallies despite A$558m US reset charge
Treasury Wine Estates rallied despite a A$558m US charge. Can stronger FY26 earnings, Penfolds and lower inventory sustain the TWE recovery?
Corporate Travel Management (ASX:CTD) wins UK Defence contract with ÂŁ28m six-month TTV forecast as ASX deadline nears
Corporate Travel Management has secured further UK Ministry of Defence work supporting the Afghan Resettlement Programme, with £28 million of transaction value forecast over the first six months. The award strengthens the operational case for customer continuity, but delayed financial statements and CTD’s continuing ASX suspension remain the more immediate investor tests.
James Hardie (ASX: JHX) jumps 5.8% as FY27 guidance rises
James Hardie shares jumped as FY27 guidance rose. Can stronger fibre-cement growth, AZEK synergies and cash flow support the recovery?
Light & Wonder, Inc. (ASX: LNW) jumps 5% as digital growth lifts Q2 margins
Light & Wonder rose 5% after Q2 margins improved. Gaming growth, digital revenue and a US$5.2bn debt load now shape the LNW outlook.
Glencore targets ASX secondary listing as surging earnings revive its copper and M&A ambitions
Glencore plans an Australian Securities Exchange secondary listing by October 2026 after first-half adjusted EBITDA surged 86%, giving Australian investors direct access to its copper, coal and commodity-trading portfolio.
Glencore (LSE: GLEN) earnings jump 86% as trading windfall funds $1.5bn shareholder return
Glencore plc has beaten first-half forecasts as commodity volatility lifted trading and mining earnings. A planned Australian listing now links its copper strategy, capital returns and unresolved merger ambitions.
Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test
Control Bionics has completed United States Food and Drug Administration establishment registration and device listing for NeuroStrip, strengthening its access to the company’s largest market while shifting investor attention toward paid adoption, subscription revenue and commercial scale.